抗氧化纳米材料对口服药片配方的影响:流量特性和关键质量属性
Andrea C Ortiz1, Javiera Carrasco-Rojas2, Sofía Peñaloza2
1Escuela de Química y Farmacia, Facultad de Ciencias, Universidad San Sebastián, Santiago 7510157, Chile.
Antioxidants (Basel, Switzerland)
|July 29, 2025
概括
与咖啡酸 (MSN-CAF) 功能化的半孔纳米粒子 (MSNs) 改善了粉末流动和药片生产. 这种抗氧化纳米材料具有生物相容性,适用于营养药和食品应用.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
- 制药科学 制药科学
背景情况:
- 抗氧化纳米材料,如带有多的半孔纳米粒子 (MSNs),为氧化敏感产品提供解决方案.
- 使用咖啡酸功能化MSN (MSN-CAF) 的目的是改进制药和营养药配方.
研究的目的:
- 调查MSN-CAF对粉末流量和片剂性能的影响.
- 评估MSN-CAF的抗氧化能力和生物相容性.
主要方法:
- 氨基化MSN被合成并与咖啡酸结合.
- 使用DPPH,ABTS,ORAC和FRAP测定方法测量了抗氧化能力.
- 粉末混合物和药片的特征是流动性和关键质量属性.
主要成果:
- 尽管孔隙被困,MSN-CAF仍然保持了显著的抗氧化活性.
- 配方F1 (10%MSN-CAF) 显示出极好的粉末流动性,并使其能够生产强大的药片.
- 药片呈现出快速分解,低脆性,在10分钟内完全释放纳米粒子,以及与HepG2细胞的生物相容性.
结论:
- MSN-CAF是一种用于直接压缩片的多功能纳米辅助剂.
- 它显示出作为食品和营养药行业的活性包装剂和配送系统的潜力.
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
192
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
192
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.0K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.0K
Factors Influencing Drug Absorption: Physicochemical Parameters
437
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
437
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
267
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
267
Factors Influencing Drug Absorption: Drug Dissolution
713
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
713
Factors Influencing Bioavailability: First-Pass Elimination
7.0K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
7.0K


